Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Pilot-scale removal of pharmaceuticals in municipal wastewater: Comparison of granular and powdered activated carbon treatment at three wastewater treatment plants
KTH, School of Biotechnology (BIO), Industrial Biotechnology.ORCID iD: 0000-0003-1621-4321
KTH, School of Biotechnology (BIO), Industrial Biotechnology.ORCID iD: 0000-0002-6979-0069
KTH, School of Biotechnology (BIO), Industrial Biotechnology.
2017 (English)In: Journal of Environmental Management, ISSN 0301-4797, E-ISSN 1095-8630, Vol. 193, no -1, 491-502 p.Article in journal (Refereed) Published
Abstract [en]

Adsorption with activated carbon is widely suggested as an option for the removal of organic micropollutants including pharmaceutically active compounds (PhACs) in wastewater. In this study adsorption with granular activated carbon (GAC) and powdered activated carbon (PAC) was analyzed and compared in parallel operation at three Swedish wastewater treatment plants with the goal to achieve a 95% PhAC removal. Initially, mapping of the prevalence of over 100 substances was performed at each plant and due to low concentrations a final 22 were selected for further evaluation. These include carbamazepine, clarithromycin and diclofenac, which currently are discussed for regulation internationally. A number of commercially available activated carbon products were initially screened using effluent wastewater. Of these, a reduced set was selected based on adsorption characteristics and cost. Experiments designed with the selected carbons in pilot-scale showed that most products could indeed remove PhACs to the target level, both on total and individual basis. In a setup using internal recirculation the PAC system achieved a 95% removal applying a fresh dose of 15–20 mg/L, while carbon usage rates for the GAC application were much broader and ranged from <28 to 230 mg/L depending on the carbon product. The performance of the PAC products generally gave better results for individual PhACs in regards to carbon availability. All carbon products showed a specific adsorption for a specific PhAC meaning that knowledge of the target pollutants must be acquired before successful design of a treatment system. In spite of different configurations and operating conditions of the different wastewater treatment plants no considerable differences regarding pharmaceutical removal were observed.

Place, publisher, year, edition, pages
Academic Press, 2017. Vol. 193, no -1, 491-502 p.
Keyword [en]
Adsorption, Advanced wastewater treatment, Municipal wastewater, PAC, Pharmaceuticals, Recirculation
National Category
Water Treatment
Research subject
Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-195703DOI: 10.1016/j.jenvman.2017.02.042ISI: 000397687100049Scopus ID: 2-s2.0-85014089196OAI: oai:DiVA.org:kth-195703DiVA: diva2:1045241
Projects
Mistra Pharma
Note

QC 20161124

Available from: 2016-11-08 Created: 2016-11-08 Last updated: 2017-05-19Bibliographically approved
In thesis
1. Towards application of activated carbon treatment for pharmaceutical removal in municipal wastewater
Open this publication in new window or tab >>Towards application of activated carbon treatment for pharmaceutical removal in municipal wastewater
2016 (English)Licentiate thesis, comprehensive summary (Other academic)
Abstract [en]

Many pharmaceuticals are found in municipal wastewater effluents due to their persistence in the human body as well as in conventional wastewater treatment processes. This discharge to the environment can lead to adverse effects in aquatic species, such as feminization of male fish. During the past decade, these findings have spawned investigations and research into suitable treatment technologies that could severely limit the discharge. Adsorption onto activated carbon has been identified as one of the two main technologies for implementation of (future) full-scale treatment.

Recent research has put a closer focus on adsorption with powdered activated carbon (PAC) than on granular activated carbon (GAC). Studies where both methods are compared in parallel operation are thus still scarce and such evaluation in pilot-scale was therefore a primary objective of this thesis. Furthermore, recirculation of PAC can be used to optimize the treatment regarding the carbon consumption. Such a setup was evaluated as a separate treatment stage to comply with Swedish wastewater convention. Additionally, variation of a set of process parameters was evaluated.

During successive operation at three different wastewater treatment plants an overall pharmaceutical removal of 95% could consistently be achieved with both methods. Furthermore, treatment with GAC was sensitive to a degraded effluent quality, which severely reduced the hydraulic capacity. Both treatment methods showed efficient removal of previously highlighted substances, such as carbamazepine and diclofenac, however in general a lower adsorption capacity was observed for GAC. By varying the input of process parameters, such as the continuously added dose or the contact time, during PAC treatment, a responsive change of the pharmaceutical removal could be achieved. The work in this thesis contributes some valuable field experience towards wider application of these treatment technologies in full-scale.

Place, publisher, year, edition, pages
Stockholm: KTH Royal Institute of Technology, 2016. 41 p.
Series
TRITA-BIO-Report, ISSN 1654-2312 ; 2016:20
Keyword
advanced wastewater treatment, granular activated carbon, powdered activated carbon, municipal wastewater treatment, pharmaceutical removal
National Category
Water Treatment
Research subject
Biotechnology
Identifiers
urn:nbn:se:kth:diva-196862 (URN)978-91-7729-197-8 (ISBN)
Presentation
2016-12-19, FB55, AlbaNova Universitetscentrum, Roslagstullsbacken 21, Stockholm, 10:00 (English)
Opponent
Supervisors
Projects
MistraPharma
Funder
Mistra - The Swedish Foundation for Strategic Environmental Research
Note

QC 20161124

Available from: 2016-11-24 Created: 2016-11-24 Last updated: 2016-11-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Kårelid, VictorLarsson, GenBjörlenius, Berndt
By organisation
Industrial Biotechnology
In the same journal
Journal of Environmental Management
Water Treatment

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 205 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf